Study at Cambridge
About the University
Research at Cambridge
Mobile menu
Mobile menu
Privacy
Cookies
Accessibility
Search
About
About
Our team
Our performance
Careers
The Cambridge ecosystem
Partnerships and collaboration
back
For the University
For the University
Tell us your idea
Be a consultant
Develop a commercial opportunity
Start a company or social venture
Develop your skills & network
Cambridge Enterprise Academic Portal
back
For external organisations
For external organisations
Find a consultant
Opportunities to invest
International outreach
Available technologies
Available research tools
Experts & Mentors Programme
back
Latest
Latest
News
Insights
Case studies
Videos
back
What’s on
Contact us
Posts Tagged ‘glaxosmithkline’
glaxosmithkline
Share:
Cambridge Enterprise
6 September 2023
Pioneering portfolio company Apollo Therapeutics closes $226.5 million round to translate fundamental medical research into medicines
Find out more
Industry
1 March 2022
Apollo Therapeutics: KE Award Winners
Find out more
Annual Review
10 February 2022
Apollo Therapeutics: Pioneering collaboration launches its next phase
Find out more
Life Sciences
22 February 2017
An update from Apollo Therapeutics
Find out more
Life Sciences
1 June 2016
Novel approach could revolutionise treatment of neuropathic pain
Find out more
Life Sciences
9 February 2016
Apollo: industry expertise and pharma muscle drives science to the clinic with unparalleled speed
Find out more
Life Sciences
25 January 2016
Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation
Find out more
Life Sciences
20 March 2014
Official opening of Cambridge labs at Stevenage Bioscience Catalyst
Find out more
Life Sciences
25 June 2013
New treatments for pain and MS being developed in open innovation programme
Find out more
Life Sciences
7 September 2012
New collaboration to develop treatments for liver disease
Find out more
Life Sciences
19 June 2012
University of Cambridge launches Open Innovation drug discovery initiative with GSK
Find out more
1
Sign up to our newsletter
Stay in touch with the latest updates from Cambridge Enterprise
Sign up now